Boomerang Ventures

Boomerang Ventures
Menu
STUDIO APPLICATION
FUND APPLICATION
BOOMERANG

NEWS

Keep up with Boomerang Ventures as we launch new companies, engage new investors, close fundraising rounds, share industry insights, and achieve other significant milestones in the life of our team and portfolio companies.
Learn More

Back to News Page

In the News
In The news

Boomerang Ventures Funds Seed-Round for SynchNeuro Wearable

Source: Business Insider
Boomerang Ventures has announced a seed-stage investment in SynchNeuro, a Philadelphia-based startup developing a brain-based, non-invasive wearable sensor to monitor blood glucose and other vital health metrics in real time. The firm’s backing supports SynchNeuro’s mission to use EEG-derived data and machine learning for proactive, needle-free cardiometabolic health insights.

Read More »
11/12/2025
In the News
In The news

Boomerang Ventures Funds Non-Invasive Glucose Startup

Source: Morningstar
Boomerang Ventures has added SynchNeuro, Inc. to its seed-stage portfolio, investing to accelerate development of the world’s first brain-based, non-invasive continuous glucose monitor. The Indianapolis-based fund is backing the startup’s EEG-driven platform that decodes brainwave signals behind the ear to monitor glucose, sleep, stress and cardiometabolic health in real time. “The brain is the richest data source imaginable,” says SynchNeuro founder Dr. Casey Halpern.

Read More »
11/12/2025
Press Release: Boomerang Ventures Makes Seed-Stage Investment in SynchNeuro to Advance Brain-Based Non-Invasive Glucose Monitoring Technology
Press Releases

Boomerang Ventures Makes Seed-Stage Investment in SynchNeuro to Advance Brain-Based Non-Invasive Glucose Monitoring Technology

Boomerang Ventures has announced a seed-stage investment in SynchNeuro, a pioneering neurotechnology company developing the world’s first brain-based, non-invasive continuous glucose monitor. The partnership accelerates SynchNeuro’s mission to revolutionize cardiometabolic health through EEG-based technology that interprets brain signals to track blood glucose and other vital metrics in real time. This innovative approach aims to make proactive, pain-free, and affordable glucose monitoring accessible to millions.

Read More »
11/12/2025

Back to News Page

Boomerang Ventures
Loading...